These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35785879)

  • 1. The comparison of exacerbation and pneumonia before and after conjugated pneumococcal vaccination in patients with chronic obstructive pulmonary disease, and the effect of inhaled corticosteroid use on results.
    Vayısoğlu Şahin G; Karadeniz G; Polat G; Yalnız E; Ayrancı A; Demirci Üçsular F; Güçsav MO
    Tuberk Toraks; 2022 Jun; 70(2):149-156. PubMed ID: 35785879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
    Walters JA; Tang JN; Poole P; Wood-Baker R
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001390. PubMed ID: 28116747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
    Tashkin DP; Strange C
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2587-2601. PubMed ID: 30214177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J; Luna Y; Wong KS; Zhang J; Chen SS; Gless PJ; Goldman DP
    Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of pneumococcal vaccination with PPV23 and PCV13 in COPD patients over a 5-year follow-up cohort study.
    Ignatova GL; Avdeev SN; Antonov VN
    Sci Rep; 2021 Aug; 11(1):15948. PubMed ID: 34354113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).
    Horita N; Goto A; Shibata Y; Ota E; Nakashima K; Nagai K; Kaneko T
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD012066. PubMed ID: 28185242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.
    Cheng SL; Su KC; Wang HC; Perng DW; Yang PC
    Drug Des Devel Ther; 2014; 8():601-7. PubMed ID: 24920884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalization for chronic obstructive pulmonary disease and pneumonia: association with the dose of inhaled corticosteroids. A nation-wide cohort study of 52 100 outpatients.
    Rønn C; Sivapalan P; Eklöf J; Kamstrup P; Biering-Sørensen T; Bonnesen B; Harboe ZB; Browatzki A; Kjærgaard JL; Meyer CN; Jensen TT; Johansson SL; Bendstrup E; Ulrik CS; Stæhr Jensen JU
    Clin Microbiol Infect; 2023 Apr; 29(4):523-529. PubMed ID: 36503112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.
    Nannini LJ; Poole P; Milan SJ; Kesterton A
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD006826. PubMed ID: 23990350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
    Morjaria JB; Rigby A; Morice AH
    Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids and the increased risk of pneumonia.
    Marzoratti L; Iannella HA; Waterer GW
    Ther Adv Respir Dis; 2013 Aug; 7(4):225-34. PubMed ID: 23445751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.
    Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N
    NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of 13-valent pneumococal conjugate polysaccharide vaccination in exacerbations rate of COPD patients with moderate to severe obstruction.
    Figueira-Gonçalves JM; Bethencourt-Martín N; Pérez-Méndez LI; Díaz-Pérez D; Guzmán-Sáenz C; Viña-Manrique P; Pedrero-García AJ
    Rev Esp Quimioter; 2017 Aug; 30(4):269-275. PubMed ID: 28585796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis.
    Hartley BF; Barnes NC; Lettis S; Compton CH; Papi A; Jones P
    Respir Res; 2020 Jan; 21(1):5. PubMed ID: 31907054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.
    Sliwka A; Jankowski M; Gross-Sondej I; Storman M; Nowobilski R; Bala MM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012355. PubMed ID: 30141826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT].
    Morros R; Vedia C; Giner-Soriano M; Casellas A; Amado E; Baena JM;
    Aten Primaria; 2019; 51(6):333-340. PubMed ID: 29661670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M; Du Y; Chen H; Jiang D; Xu Z
    Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.